Shenzhen Salubris Pharmaceuticals (002294.SZ): Enalapril (enalapril maleate tablets) receives new indications in drug registration certificate.
Shineway Technologies (002294.SZ) announced that the company has received approval from the National Medical Products Administration for the issuance of Enda Duotze tablets...
Shenzhen Salubris Pharmaceuticals (002294.SZ) announced that the company has received the approved and issued drug registration certificate for the drug Enarodustat Tablets (Enarol) from the National Medical Products Administration. The drug is approved for the treatment of anemia in chronic kidney disease (CKD) patients undergoing dialysis (including hemodialysis and peritoneal dialysis).
Related Articles

Is the A share adjustment coming to an end? What are the main investment themes? Top ten securities firms' strategies are here.

WH Group (00288): Chairman of the Board, Wan Long, purchased 1.8 million shares of Smithfield stock in the second issuance.

C TRANSMISSION(00658): Guowei has been appointed as the new lead auditor.
Is the A share adjustment coming to an end? What are the main investment themes? Top ten securities firms' strategies are here.

WH Group (00288): Chairman of the Board, Wan Long, purchased 1.8 million shares of Smithfield stock in the second issuance.

C TRANSMISSION(00658): Guowei has been appointed as the new lead auditor.

RECOMMEND

“Land King Harvester” Greentown Sees Profits Plunge 90% to RMB 210 Million as “Survival Becomes Paramount”
04/09/2025

Fed’s Beige Book Reveals Multiple Economic Concerns: Slowing Hiring, Rising Prices, Cautious Consumers
04/09/2025

U.S. Tariff Receipts Soar Past $31 Billion in August, Setting New Monthly Record
04/09/2025